“Relapse”的搜索结果，显示 31-40 项，共有 2431 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

3. 血液科- 临床试验- 妙佑医疗国际

   A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma. Rochester, Minn ...

4. 霍奇金淋巴瘤（霍奇金病） - 症状与病因- 妙佑医疗国际

   LaCasce AS. Treatment of relapsed or refractory classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025. Chemotherapy to ...

5. 血液科- 临床试验- 妙佑医疗国际

   ... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... relapse, and subsequent therapy. Effect of Agent Orange ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... Relapsed Favorable Histology Wilms Tumors A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT. Rochester, Minn. The ...